Transient changes in thyroid functions tests after zoledronic acid infusion

Endocrine Journal

Volumn 58, Issue 11, 2011, Pages 969-977

  Karga, Helen ^a   Giagourta, Irene ^a   Papaioannou, Garyphallia ^a   Katsichti, Paraskevi ^a   Pardalakis, Argyris ^a   Kassi, Georgia ^a   Zagoreou, Apostolia ^a   Triantaphyllopoulou, Maria ^a   Zerva, Cherry ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

Aminobisphosphonates; Cortisol; Cytokines; Lymphocytes; Thyroid

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; LIOTHYRONINE; PLACEBO; THYROID HORMONE; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; ZOLEDRONIC ACID;

ACUTE PHASE RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LEUKOCYTE; LIOTHYRONINE BLOOD LEVEL; OSTEOPOROSIS; POSTMENOPAUSE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SIDE EFFECT; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 82855178927     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0039     Document Type: Article

References (26)

1. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cayley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR; HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356: 1809-1822.
2. Reid IR, Miller P, Lyles K, Frasen W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparson of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 353: 898-908.
3. Coleman R, Cook R, Hirsh V, Major P, Lipton A (2011) Zoledronic acid use in cancer patients: more than just supportive care? Cancer 117: 11-23.
4. Thiébaud D, Sauty A, Burckhardt P, Leunberger P, Sitzler ZL, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61: 386-392.
5. Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zolendronic acid. J Clin Endocrinol Metab 95: 4380-4387.
6. Dicuonzo G, Vincenzi B, Santini D, Santini D, Avvisati G, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G (2003) Fever after zolendronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 23(11): 649-654.
7. DeGroot LJ (1999) Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J Clin Endocrinol Metab 84: 151-164.
8. Adler SM, Wartofsky L (2007) The nonthyroidal illness syndrome. Endocrinol Metab Clin N Am 36: 657-672.
9. Warner MH, Beckett GJ (2010) Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 205: 1-13.
10. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR (2005) Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115: 2524-2533.
11. Boelen A, Kwakkel J, Wieland CW, StGermain DL, Fliers E, Hernandez A (2009) Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with streptococcus pneumoniae. Endocrinology 150: 1984-1133.
12. Chen T, Berenson J, Vescio R, Swift R, Glichick A, Goodin S, LoRusso P, Ma P, Ravera C, Deckert F, Schran H, Seaman J, Skerjanec A (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone matastases. J Clin Pharmacol 42: 1228-1236.
13. Graham GG, Day RO, Milligan MK, Ziegler JB, Kettle AJ (1999) Current concepts of the actions of paracetamol (acetaminophen) and NSAIDs. Inflammopharmacology 7: 255-263.
14. Faber J (1980) Lack of effect of acetaminophen on serum T4,T3 reverse T3,3,3'-iiodothyronine and 3'5'- diiodothyronine in man. Horm Metab Res 12: 637-638.
15. Samuels MH, Pillots K, Asher D, Nelson JC (2003) Variable effects of nonsteroidal antiinflammatory agents on thyroid test results. J Clin Endocrinol Metab 88: 5710-5716.
16. Hewitt RE, Lissina A, Green A, Slay ES, Price DA, Sewell AK (2005) The bisphosphonate acute phase response: rapid and copius production of proinflammatory cytokines by peripheral blood γδT cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol 139: 101-111.
17. Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V (1987) The acute-phase response after bisphosphonate administration. Calcif Tissue Int 41: 326-331.
18. Docter R, Krenning EP, de Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 39: 499-518.
19. Sánchez E, Singru PS, Fekete C, Lechan RM (2008) Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by becterial lipopolysaccharide: role of corticosterone. Endocrinology 149: 2484-2493.
20. Karga H, Papaioannou P, Venetsanou K, Papandroulaki F, Karaloizos L, Papaioannou G, Papapetrou P (2000) The role of cytokines and cortisol in the nonthyroidal illness syndrome following acute myocardial infarction. Eur J Endocrinol 142: 236-242.
21. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V (2001) Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNF alpha in nonthyroidal illness syndrome by abdominal surgery. J Clin Endocrinol Metab 86: 4198-4205.
22. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM (2004) Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 182: 315-323.
23. Stouthard JM, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, Romijn JA (1994) Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79: 1342-1346.
24. Boelen A, Kwakkel J, Platvoet-ter Schiphorst MP, Mentrup B, Baur A, Koehrle J, Iersinga WM (2004) Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. Eur J Endocrinol 151: 497-502.
25. Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA (1991) Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 68: 2384-2390.
26. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch JP, Lemmonier C, Benhamou JP, Bok B (1993) Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) 39: 657-661.